CRON (STOCKS)
Cronos Group Inc. Common Share
$3.146200
-0.023800 (-0.75%)
Prev close: $3.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Michael Ryan Gorenstein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,304.71M
- Employees
- 459
- P/E (TTM)
- 17.21
- P/B (TTM)
- 1.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.04 | $0.00 | +0.0400 | +0.00% |
|
Dec 2025 (Q4)
|
$0.00 | $0.01 | -0.0142 | -139.22% |
|
Sep 2025 (Q3)
|
$0.08 | $0.00 | +0.0800 | +0.00% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.02 | -0.0796 | -390.20% |
Financial Statements
| Revenues | $179.09M |
| Benefits Costs and Expenses | $110.62M |
| Cost Of Revenue | $96.96M |
| Costs And Expenses | $110.62M |
| Gross Profit | $82.13M |
| Nonoperating Income/Loss | $70.90M |
| Operating Expenses | $84.55M |
| Depreciation and Amortization | $1.56M |
| Research and Development | $5.36M |
| Other Operating Expenses | $77.64M |
| Operating Income/Loss | -$2.43M |
| Income/Loss From Continuing Operations After Tax | $79.20M |
| Income/Loss From Continuing Operations Before Tax | $68.47M |
| Income Tax Expense/Benefit | -$10.73M |
| Net Income/Loss | $79.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $9.23M |
| Net Income/Loss Attributable To Parent | $69.98M |
| Net Income/Loss Available To Common Stockholders, Basic | $71.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.20 |
| Diluted Earnings Per Share | $0.20 |
| Basic Average Shares | 1,135,754,089 |
| Diluted Average Shares | 1,141,537,622 |
| Assets | $1.18B |
| Current Assets | $912.03M |
| Inventory | $52.70M |
| Other Current Assets | $859.33M |
| Noncurrent Assets | $267.83M |
| Fixed Assets | $141.54M |
| Intangible Assets | $8.05M |
| Other Non-current Assets | $118.24M |
| Liabilities | $62.42M |
| Current Liabilities | $56.36M |
| Accounts Payable | $17.42M |
| Other Current Liabilities | $38.94M |
| Noncurrent Liabilities | $6.05M |
| Equity | $1.12B |
| Equity Attributable To Noncontrolling Interest | $48.77M |
| Equity Attributable To Parent | $1.07B |
| Liabilities And Equity | $1.18B |
| Net Cash Flow From Operating Activities | $60.05M |
| Net Cash Flow From Operating Activities, Continuing | $60.05M |
| Net Cash Flow From Investing Activities | -$340.49M |
| Net Cash Flow From Investing Activities, Continuing | -$340.49M |
| Net Cash Flow From Financing Activities | -$48.44M |
| Net Cash Flow From Financing Activities, Continuing | -$48.44M |
| Exchange Gains/Losses | $1.48M |
| Net Cash Flow | -$327.40M |
| Net Cash Flow, Continuing | -$328.88M |
| Comprehensive Income/Loss | $29.77M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.11M |
| Comprehensive Income/Loss Attributable To Parent | $22.66M |
| Other Comprehensive Income/Loss | -$31.49M |